Liu, L., Sun, X., Quan, T., Li, X., Guo, L., Mo, H., Guo, S., Liu, S., Huang, Y., Luo, D., Sun, R., Jia, G., Li, J., Liu, Q., Wang, P., Liang, Y., Chen, J., Li, Y., Cheng, H., Xia, W., Qiu, F., Yang, J., Yang, Q., Wen, D., Yan, J., Zhao, C., Chen, Q., Tang, L., Mai, H. (2026). Concurrent chemoradiotherapy plus nimotuzumab versus chemoradiotherapy alone for locoregionally advanced nasopharyngeal carcinoma with a suboptimal response to induction chemotherapy: a randomized phase 2 trial. Nature Communications. https://doi.org/10.1038/s41467-026-71019-5